Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSEPH P ERINJERI

Allopathic & Osteopathic Physicians Radiology Vascular & Interventional Radiology

NPI
1437289048
CMS profile
20148
Location
NEW YORK, NY

General Payments · PY2018–2024

$53,614.31

  • Reported across 54 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$14,266.16

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
AstraZeneca UK Limited $8,609.15 8
Acerta Pharma LLC $5,338.50 3
Inari Medical, Inc. $175.96 3
Surefire Medical, Inc. $142.55 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $6,480.71 9
PY2019 $6,404.32 14
PY2020 $7,700.00 2
PY2021 $130.28 1
PY2022 $506.64 4
PY2023 $18,126.20 9
PY2024 $14,266.16 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $135.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 1105748179 CMS
AstraZeneca Pharmaceuticals LP $2,953.50 02/07/2024 Consulting Fee Undisputed 01/23/2026 1105685419 CMS
AstraZeneca Pharmaceuticals LP $2,250.00 03/03/2024 Consulting Fee Undisputed 01/23/2026 1104213103 CMS
AstraZeneca UK Limited $1,342.50 03/01/2024 Consulting Fee Undisputed 01/23/2026 1093935224 CMS
AstraZeneca UK Limited $205.00 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1093888021 CMS
AstraZeneca UK Limited $1,383.85 05/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1093917647 CMS
AstraZeneca UK Limited $111.87 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1093921462 CMS
AstraZeneca UK Limited $1,109.11 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1093947643 CMS
AstraZeneca UK Limited $26.57 05/08/2024 Food and Beverage Undisputed 01/23/2026 1093953080 CMS
AstraZeneca UK Limited $3,356.25 05/16/2024 Consulting Fee Undisputed 01/23/2026 1093897230 CMS
AstraZeneca UK Limited $1,074.00 07/22/2024 Consulting Fee Undisputed 01/23/2026 1093987526 CMS
Inari Medical, Inc. $70.48 01/19/2024 Food and Beverage Undisputed 01/23/2026 1140087921 CMS
Inari Medical, Inc. $37.68 03/18/2024 Food and Beverage Undisputed 01/23/2026 1140087927 CMS
Inari Medical, Inc. $67.80 04/05/2024 Food and Beverage Undisputed 01/23/2026 1140087932 CMS
TriSalus Life Sciences, Inc. $142.55 03/26/2024 Food and Beverage Undisputed 01/23/2026 1128556444 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.